Agrigenomics Market : Business Opportunities and Global Industry Analysis

The global agrigenomics market is estimated at USD 3.3 billion in 2021 and is projected to reach USD 5.3 billion by 2026, at a CAGR of 9.7% from 2021 to 2026. The global marketplace has witnessed a significant increase in crop genomic resources and advancements in genome analysis facilitating basic and translational agricultural research. This trend is expected to continue strongly throughout the forecast period.

North America  is estimated to hold the largest market share during the forecast period

North America dominated the agrigenomics market due to the strong R&D, technology innovation, and increased mergers and acquisitions in agrigenomics in the region. North America is the largest market for agrigenomics services and solutions globally; this is attributed to the numerous key technology providers, streamlined policy and regulatory framework, and effective research processes. The number of in-house testing laboratories in North America has also doubled since the 1990s, with the aim to develop more sustainable agricultural products (both crop- and livestock-related). The role of contract research organizations has also increased in North America, leading to the prospects of commercialization of agrigenomics testing services.

Request for Sample of this Report:

Eurofins Scientific SE (Luxembourg)  is an international group of laboratories that provide testing and support services to the pharmaceutical, food, environmental & consumer products industries, and to governments. The company capitalizes on a portfolio of over 130,000 reliable analytical methods that allowed it to offer services that characterize the safety, identity, purity, composition, authenticity, and origin of products and biological substances.

With global operations, the company provides testing services such as food & feed testing, environment testing, genomic services, forensic services, agroscience services, consumer products testing, and human safety testing. With regard to genomic services, Eurofins Agrigenomics is a global network of genetic testing laboratories offering a variety of services for livestock and other animal industries with the goal of supporting their breeding strategies and projects. It has several locations dedicated to animal genetic testing. The company has been involved in the development of the latest and advanced technologies domestically or through acquisitions and in-licensing. It provides services to plant and livestock breeders based on custom DNA sequencing, next-generation sequencing, gene synthesis, and genotyping, among others. Eurofins Scientific operates through 170 locations in 32 countries.

Thermo Fisher Scientific, Inc. (US) was formed through the merger between Thermo Electron Corporation (US) and Fisher Scientific International, Inc. (US). It offers a complete and integrated portfolio of solutions and services for laboratory research and analysis, healthcare and clinical science, manufacturing, and other fields. The company targets four principal market segments: pharmaceutical & biotech, academic & government, diagnostics & healthcare, and industrial & applied. The company’s product segments include consumables, instruments, equipment & software, and services. The company operates in over 150 countries across North America, Europe, Asia, and Latin America.

Agilent Technologies, Inc. (US) was established in 1999 after demerging with Hewlett-Packard Company as part of a corporate rearrangement. It is engaged in the designing and manufacturing of electronic and bio-analytical instruments. The company operates through three business segments: life sciences and applied markets, diagnostics & genomics, and Agilent CrossLab. The life sciences & applied markets segment deals with Agilent’s analytical laboratory instrumentation and informatics, whereas Agilent CrossLab provides analytical laboratory services and consumables.

Make an Inquiry:

The third business segment, diagnostics & genomics, concentrates on three functional areas—pathology & companion diagnostics, genomic solutions (including arrays and NGS target enrichment), and nucleic acid solutions providing synthetic RNA for pharmaceuticals. The company has a global presence in the Americas, Europe, the Middle East, Asia, and Africa, and operates in more than 100 countries.

Comments are closed